Search
Sunday 18 October 2015
  • :
  • :

(DRNA) (MJN) (ADI) (DFS) Active News Update: Dicerna Pharmaceuticals (NASDAQ:DRNA), Mead Johnson Nutrition (NYSE:MJN), Analog Devices (NASDAQ:ADI), Discover Financial (NYSE:DFS)

On Tuesday, Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)’s shares declined -7.21% to $8.24.

Dicerna Pharmaceuticals, Inc. (DRNA), a leader in the development of RNA interference-based therapeutics targeting rare inherited diseases involving the liver and for cancers that are genetically defined, recently declared that on September 30, 2015, the Compensation Committee of the Company’s Board of Directors approved the grant of inducement stock options to purchase a total of 195,700 shares of common stock to six new employees, with all six grants having a grant date of September 30, 2015 (the “Q3 2015 Inducement Grants”).

Each of the Q3 2015 Inducement Grants has an exercise price per share equal to $8.21, the fair market value on the grant date. Each stock option vests over four years, with 25% vesting on the one-year anniversary of the employee’s first day of employment with the Company and 1/48 of the shares vesting monthly thereafter, subject to the new employee’s continued service relationship with the Company on each such date. Each stock option has a ten year term and is subject to the terms and conditions of the applicable stock option agreement.

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally.

Mead Johnson Nutrition CO (NYSE:MJN)’s shares dropped -0.09% to $75.09.

Mead Johnson Nutrition Company (MJN) declared it is unveiling a new, innovative plastic bottle for its 32 fluid ounce ready-to-use family of Enfamil® products. Now, parents and caregivers can find the new packaging at major retailers across the nation.

The new, modern packaging with an easy-to-grip shape is designed to provide control while pouring. It brings convenience to busy parents by allowing them to prepare multiple bottles at a time. Importantly, it also ensures accurate proportions due to the formula being premixed. The bottle keeps the product fresh without refrigeration due to its shelf-stable technology, meaning the product stays fresh in the pantry until its stated expiration date or until it’s opened and needs to be stored in the refrigerator.

In addition to the sleek, easy-to-use 32 fluid ounce ready-to-use bottle, the Enfamil brand offers a nipple-ready 2 fluid ounce Nursette® bottle for newborns – which is especially convenient for late-night feedings – and an 8 fluid ounce ready-to-use bottle to support changing feeding needs as babies grow.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products.

At the end of Tuesday’s trade, Analog Devices, Inc. (NASDAQ:ADI)‘s shares dipped -0.94% to $56.89.

Analog Devices, Inc. (ADI) declared it is the primary sponsor and founding member of “Solve,” a multi-faceted program organized by the Massachusetts Institute of Technology (MIT) that convenes thought leaders, researchers, students, and change agents to identify and implement technology-centered solutions to the most difficult challenges of our times. Solve is part of HUBweek, a week-long city-wide festival taking place October 3-10, 2015, that will celebrate ideas and innovation in the Boston area. Solve kicks off with an inaugural event planned for October 5-8, 2015, at MIT. Solve is an ongoing initiative with participants reconvening regularly to share insights and move toward finding solutions.

Analog Devices, Inc. engages in the design, manufacture, and marketing of analog, mixed-signal, and digital signal processing integrated circuits (ICs) for use in industrial, automotive, consumer, and communication markets worldwide.

Discover Financial Services (NYSE:DFS), ended its Tuesday’s trading session with 0.02% gained, and closed at $54.56.

Discover Financial Services (DFS) plans to report its third quarter 2015 results after the market closes on Tuesday, October 20, 2015. The earnings release will be accessible on Discover’s corporate website at www.investorrelations.discoverfinancial.com.

Discover Financial Services operates as a direct banking and payment services company in the United States. It operates in two segments, Direct Banking and Payment Services.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *